Clinical commissioning policy: Lenacapavir for multi-drug resistant human immunodeficiency virus 1 infection (adults)

Document first published:
Page updated:
Topic:
Publication type:
,

Lenacapavir for mult-drug resistant human immunodeficiency virus 1 will be routinely commissioned and made by NHS England following a recommendation from the Clinical Priorities Advisory Group.

Summary

PDF format. Published 6 August 2026.

Summary

PDF format. Published 6 August 2026.